FDA Approved: SYMFI — Original Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved Symfi, a fixed-dose combination tablet of efavirenz, lamivudine, and tenofovir disoproxil fumarate, under NDA 022142 by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SYMFI (EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

ORIG AP for SYMFI (EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)